1. Home
  2. NGVT vs VCEL Comparison

NGVT vs VCEL Comparison

Compare NGVT & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingevity Corporation

NGVT

Ingevity Corporation

HOLD

Current Price

$65.64

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$37.82

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NGVT
VCEL
Founded
1964
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
NGVT
VCEL
Price
$65.64
$37.82
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$65.00
$57.50
AVG Volume (30 Days)
290.6K
597.0K
Earning Date
02-17-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
236.54
EPS
N/A
0.25
Revenue
$1,382,100,000.00
$258,716,999.00
Revenue This Year
N/A
$17.86
Revenue Next Year
$2.28
$18.55
P/E Ratio
N/A
$150.23
Revenue Growth
5.63
14.05
52 Week Low
$28.49
$29.24
52 Week High
$66.59
$63.00

Technical Indicators

Market Signals
Indicator
NGVT
VCEL
Relative Strength Index (RSI) 75.20 50.35
Support Level $58.87 $36.12
Resistance Level $63.03 $41.65
Average True Range (ATR) 1.52 1.59
MACD 0.38 0.09
Stochastic Oscillator 88.86 38.92

Price Performance

Historical Comparison
NGVT
VCEL

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: